'Maintenance treatment' presentation slideshows

Richard Elovich, MPH Columbia University Mailman School of Public Health Medical Sociologist

Oral Substitution Treatment for Opioid Dependence: A Training in Best Practices & Program Design for Nepal. Day 2. March 26-28, 2006 Kathmandu, Nepal UNDP. Richard Elovich, MPH Columbia University Mailman School of Public Health Medical Sociologist

1.37k views • 122 slides

Medication Assisted Treatment (MAT) in Pregnant Women

Medication Assisted Treatment (MAT) in Pregnant Women. Susan F. Neshin, M.D. Medical Director JSAS Healthcare, Inc. Asbury Park, NJ E-mail: jsasmd@aol.com. Overview of Presentation. What is MAT? Rationale for MAT Importance of Dose Adequacy Impact of MAT The Medications

995 views • 68 slides

Treatment of Schizophrenia (and Related Psychotic Disorders)

967 views • 48 slides

Medication Assisted Treatment (MAT) Issues for Women

Medication Assisted Treatment (MAT) Issues for Women. Susan F. Neshin, MD Medical Director JSAS Healthcare, Inc. Asbury Park, NJ E-mail: jsasmd@aol.com. What is MAT?. MAT=Medication Assisted Treatment EUPHEMISM for opioid maintenance therapy Methadone Buprenorphine Broaden definition

644 views • 46 slides

Integration Models into Primary Health Care: the Example of Late-life Depression

Integration Models into Primary Health Care: the Example of Late-life Depression. Benoit H. Mulsant, MD, MS, FRCPC Professor and Vice-Chair Department of Psychiatry University of Toronto Physician in Chief Centre for Addiction and Mental Health. L earning Objectives.

644 views • 40 slides

Harm reduction; Iranian case

Harm reduction; Iranian case. Bijan Nassirimanesh, MD Aug 2006, Toronto AID conference bijan@ahrn.net. Iran: An example of moving from one pillar approach in 1979 to 4-pilar approach at 2006.

526 views • 38 slides

Inflammatory Bowel Disease

487 views • 32 slides

Cost Effectiveness of Maintenance Treatment for Heroin Addicts

Cost Effectiveness of Maintenance Treatment for Heroin Addicts. Professor Margaret Brandeau Department of Management Science and Engineering with Greg Zaric, U. Western Ontario Paul Barnett, Palo Alto VA. Outline of Talk. Background

454 views • 32 slides

H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director Center for Substance Abuse Treatment Substance Abuse Mental H

Applying the Substance Abuse Confidentiality Regulations to Behavioral Health Primary Care Providers. H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director Center for Substance Abuse Treatment Substance Abuse Mental Health Services Administration

564 views • 27 slides

A COMBINATION APPROACH TO HIV PREVENTION

GLOBAL AIDS UPDATE 2019. A COMBINATION APPROACH TO HIV PREVENTION. Prevalence of unsupressed HIV (>1,000 copies/ml) among adults (aged 15 years and older), eastern and southern Africa, 2018. Unsuppressed HIV (%). 30. 25. 20. 15. 10. 5. 0.

248 views • 22 slides

Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective

Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective. Marek C. Chawarski Yale University School of Medicine. HIV/AIDS cases among IDUs. No Data Reported. 0% HIV/AIDS cases among IDUs. < 10% HIV/AIDS cases among IDUs.

398 views • 21 slides

Quarter 2 List

Quarter 2 List. PREFIXES. Ante- before. antechoir. The clergy stood in the antechoir in front of the choir at church . Works Cited Microsoft Clip Art. Novice- new, inexperienced novice, neoclassical, neonatology, Neolithic The caveman was a novice to the new invention of fire.

377 views • 19 slides

??? ???? ?????? ??????

??? ???? ?????? ??????. ?Anti-psychotics. Dr: Samah Gaafar Hassan Al-shaygi. Schezophrenia represents a heterogeneous syndrome of disorganized and bizarre thoughts, delusions, hallucinations, inappropriate affect, and impaired psychosocial functioning.

287 views • 16 slides

330 views • 13 slides

Long-term Efficacy Data for Psychiatric Drugs Rationale for Long-Term Treatment

Long-term Efficacy Data for Psychiatric Drugs Rationale for Long-Term Treatment. Earl Giller, MD, PhD Pfizer Global Research & Development. Long-Term Efficacy for Psychiatric Drugs Psychopharmacology Drugs Advisory Committee October 25, 2005. Overview.

310 views • 10 slides

The Research Question

The Research Question. Background: Increasing SSRI prescription is largely driven by use of maintenance therapy There is no evidence from RCTS for maintenance treatment in primary care patients Question: What is the effectiveness of maintenance SSRI

56 views • 4 slides